Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction

NCT: NCT07771660 · COMPLETED

NCT IDNCT07771660
StatusCOMPLETED
Start Date2024-04-10
Completion2025-12-09
SponsorAnkara University (OTHER)
First posted
Last updated

Brief Summary

This clinical study compared two orthopedic treatment approaches for growing patients with skeletal Class III malocclusion associated primarily with maxillary deficiency: the Ertty Gap III appliance and facemask therapy. Participants assigned to active treatment received either Ertty Gap III or facemask therapy, while an untreated historical Class III group was used as a reference for growth-related changes. The main objective was to compare the skeletal effects of the two treatment approaches, particularly changes in the sagittal relationship between the maxilla and mandible. Dentoalveolar, vertical skeletal, and soft tissue changes were also evaluated. Lateral cephalometric radiographs obtained before treatment and after correction of the anterior crossbite and achievement of a positive overjet were used for the assessments.

Frequently Asked Questions

What is Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction?

Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction is a clinical trial registered under NCT07771660. Current status: COMPLETED.

What is the status of NCT07771660?

The current status of NCT07771660 (Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction) is: COMPLETED.

When did Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction start?

Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction started on 2024-04-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.